PulseSight Therapeutics SAS, an ophthalmology clinical stage biotech company developing disruptive non-viral vectorized gene therapies with minimally-invasive delivery technology, has reported the ...

Detailed price information for Bausch & Lomb Corp (BLCO-N) from The Globe and Mail including charting and trades.

Data show promising and sustained improvements across key measures of visual function, including low luminance visual acuity and mean macular ...

Beacon Therapeutics Holdings Limited (Beacon Therapeutics or the Company), a leading clinical-stage biotechnology company ...

A treatment that targets dysfunctional photoreceptors regardless of the underlying genetic mutation leads to improved ...

VisioCore Scam or Legit? Lutein, Zeaxanthin, and Bilberry Formula Ingredients, $59 Pricing, and 60-Day Guarantee Explained ...

Data show promising and sustained improvements across key measures of visual function, including low luminance visual acuity and mean macular sensitivity as measured by microperimetry.Laru-zova was ge ...

For decades, Chinese hamster ovary (CHO) cells have been the gold standard for producing biologic drugs, from monoclonal ...

Roughly 200 million people worldwide live with age-related macular degeneration, a condition that erodes central vision and, in its advanced dry form, has no approved treatment that can reverse the ...

Discusses BGE-102 Clinical Results and Development Strategy for Cardiovascular and Retinal Disease May 8, 2026 12:30 PM ...

Startups have developed chips that allow people to control machines with their thoughts. Billionaires are betting these brain ...

The use of sunglasses that block all UVA and UVB rays, together with wide-brimmed hats, provides effective protection against ...